annual EBIT:
-$195.08M-$53.04M(-37.34%)Summary
- As of today (June 27, 2025), CLDX annual earnings before interest & taxes is -$195.08 million, with the most recent change of -$53.04 million (-37.34%) on December 31, 2024.
- During the last 3 years, CLDX annual EBIT has fallen by -$125.93 million (-182.12%).
- CLDX annual EBIT is now -16210.87% below its all-time high of -$1.20 million, reached on December 31, 2010.
Performance
CLDX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$62.74M-$6.71M(-11.98%)Summary
- As of today (June 27, 2025), CLDX quarterly earnings before interest & taxes is -$62.74 million, with the most recent change of -$6.71 million (-11.98%) on March 31, 2025.
- Over the past year, CLDX quarterly EBIT has dropped by -$22.13 million (-54.50%).
- CLDX quarterly EBIT is now -337.42% below its all-time high of $26.43 million, reached on December 31, 2010.
Performance
CLDX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$217.21M-$22.13M(-11.34%)Summary
- As of today (June 27, 2025), CLDX TTM earnings before interest & taxes is -$217.21 million, with the most recent change of -$22.13 million (-11.34%) on March 31, 2025.
- Over the past year, CLDX TTM EBIT has dropped by -$67.03 million (-44.63%).
- CLDX TTM EBIT is now -5036.57% below its all-time high of $4.40 million, reached on April 30, 1990.
Performance
CLDX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CLDX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.3% | -54.5% | -44.6% |
| 3 y3 years | -182.1% | -163.7% | -182.9% |
| 5 y5 years | -257.8% | -396.6% | -313.4% |
CLDX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -182.1% | at low | -163.7% | at low | -182.9% | at low |
| 5 y | 5-year | -293.5% | at low | -511.3% | at low | -338.2% | at low |
| alltime | all time | <-9999.0% | at low | -337.4% | at low | -5036.6% | at low |
CLDX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$62.74M(+12.0%) | -$217.21M(+11.3%) |
| Dec 2024 | -$195.08M(+37.3%) | -$56.03M(+7.5%) | -$195.08M(+12.0%) |
| Sep 2024 | - | -$52.13M(+12.5%) | -$174.18M(+6.7%) |
| Jun 2024 | - | -$46.32M(+14.1%) | -$163.29M(+8.7%) |
| Mar 2024 | - | -$40.61M(+15.6%) | -$150.18M(+5.7%) |
| Dec 2023 | -$142.04M(+32.6%) | -$35.13M(-14.8%) | -$142.04M(+5.4%) |
| Sep 2023 | - | -$41.24M(+24.2%) | -$134.80M(+11.2%) |
| Jun 2023 | - | -$33.20M(+2.3%) | -$121.26M(+4.7%) |
| Mar 2023 | - | -$32.47M(+16.4%) | -$115.77M(+8.1%) |
| Dec 2022 | -$107.10M(+54.9%) | -$27.89M(+0.7%) | -$107.10M(+7.3%) |
| Sep 2022 | - | -$27.70M(-0.1%) | -$99.80M(+9.3%) |
| Jun 2022 | - | -$27.72M(+16.5%) | -$91.33M(+18.9%) |
| Mar 2022 | - | -$23.79M(+15.6%) | -$76.78M(+11.0%) |
| Dec 2021 | -$69.15M(+39.5%) | -$20.59M(+7.1%) | -$69.15M(+17.5%) |
| Sep 2021 | - | -$19.23M(+45.8%) | -$58.83M(+10.4%) |
| Jun 2021 | - | -$13.18M(-18.4%) | -$53.28M(+0.3%) |
| Mar 2021 | - | -$16.16M(+57.4%) | -$53.10M(+7.1%) |
| Dec 2020 | -$49.57M(-9.1%) | -$10.26M(-25.0%) | -$49.57M(-4.6%) |
| Sep 2020 | - | -$13.68M(+5.3%) | -$51.98M(-0.5%) |
| Jun 2020 | - | -$13.00M(+2.9%) | -$52.26M(-0.5%) |
| Mar 2020 | - | -$12.63M(-0.3%) | -$52.54M(-3.6%) |
| Dec 2019 | -$54.52M(-28.6%) | -$12.67M(-9.2%) | -$54.52M(-2.0%) |
| Sep 2019 | - | -$13.96M(+5.2%) | -$55.63M(-1.3%) |
| Jun 2019 | - | -$13.27M(-9.2%) | -$56.37M(-16.4%) |
| Mar 2019 | - | -$14.62M(+6.1%) | -$67.40M(-11.8%) |
| Dec 2018 | -$76.40M(-30.1%) | -$13.78M(-6.3%) | -$76.41M(-13.9%) |
| Sep 2018 | - | -$14.70M(-39.5%) | -$88.75M(-9.1%) |
| Jun 2018 | - | -$24.31M(+2.9%) | -$97.62M(-3.6%) |
| Mar 2018 | - | -$23.62M(-9.6%) | -$101.24M(-7.4%) |
| Dec 2017 | -$109.33M(-17.7%) | -$26.13M(+10.9%) | -$109.33M(-7.4%) |
| Sep 2017 | - | -$23.56M(-15.6%) | -$118.05M(-5.2%) |
| Jun 2017 | - | -$27.93M(-11.9%) | -$124.48M(-3.4%) |
| Mar 2017 | - | -$31.71M(-9.0%) | -$128.92M(-3.0%) |
| Dec 2016 | -$132.92M(+2.6%) | -$34.85M(+16.2%) | -$132.91M(+1.1%) |
| Sep 2016 | - | -$29.99M(-7.3%) | -$131.50M(-1.8%) |
| Jun 2016 | - | -$32.37M(-9.3%) | -$133.88M(-0.3%) |
| Mar 2016 | - | -$35.70M(+6.8%) | -$134.26M(+3.6%) |
| Dec 2015 | -$129.54M(+5.8%) | -$33.44M(+3.3%) | -$129.54M(+1.1%) |
| Sep 2015 | - | -$32.37M(-1.2%) | -$128.15M(+1.6%) |
| Jun 2015 | - | -$32.75M(+5.7%) | -$126.12M(+3.4%) |
| Mar 2015 | - | -$30.98M(-3.3%) | -$121.92M(-0.4%) |
| Dec 2014 | -$122.43M(+51.9%) | -$32.05M(+5.6%) | -$122.43M(+9.0%) |
| Sep 2014 | - | -$30.34M(+6.3%) | -$112.36M(+6.9%) |
| Jun 2014 | - | -$28.55M(-9.3%) | -$105.14M(+10.6%) |
| Mar 2014 | - | -$31.49M(+43.3%) | -$95.09M(+17.9%) |
| Dec 2013 | -$80.62M(+40.1%) | -$21.98M(-5.0%) | -$80.62M(+7.4%) |
| Sep 2013 | - | -$23.13M(+25.0%) | -$75.10M(+12.7%) |
| Jun 2013 | - | -$18.50M(+8.7%) | -$66.62M(+8.4%) |
| Mar 2013 | - | -$17.02M(+3.4%) | -$61.49M(+6.8%) |
| Dec 2012 | -$57.55M(+33.8%) | -$16.46M(+12.4%) | -$57.55M(+7.8%) |
| Sep 2012 | - | -$14.65M(+9.6%) | -$53.38M(+6.6%) |
| Jun 2012 | - | -$13.36M(+2.1%) | -$50.07M(+7.5%) |
| Mar 2012 | - | -$13.08M(+6.4%) | -$46.59M(+7.9%) |
| Dec 2011 | -$43.00M(+3495.6%) | -$12.29M(+8.5%) | -$43.17M(+870.5%) |
| Sep 2011 | - | -$11.33M(+14.7%) | -$4.45M(+117.7%) |
| Jun 2011 | - | -$9.88M(+2.3%) | -$2.04M(+41.1%) |
| Mar 2011 | - | -$9.66M(-136.5%) | -$1.45M(+21.0%) |
| Dec 2010 | -$1.20M(-96.7%) | $26.43M(-395.9%) | -$1.20M(-97.0%) |
| Sep 2010 | - | -$8.93M(-3.8%) | -$40.56M(+4.6%) |
| Jun 2010 | - | -$9.29M(-1.3%) | -$38.79M(+1.5%) |
| Mar 2010 | - | -$9.41M(-27.3%) | -$38.22M(+4.4%) |
| Dec 2009 | -$36.60M(-22.7%) | -$12.94M(+80.8%) | -$36.60M(-18.0%) |
| Sep 2009 | - | -$7.16M(-18.0%) | -$44.65M(-3.1%) |
| Jun 2009 | - | -$8.72M(+12.0%) | -$46.07M(-3.4%) |
| Mar 2009 | - | -$7.79M(-62.9%) | -$47.71M(+0.8%) |
| Dec 2008 | -$47.34M(+205.3%) | -$20.99M(+144.7%) | -$47.34M(+54.5%) |
| Sep 2008 | - | -$8.58M(-17.2%) | -$30.65M(+16.8%) |
| Jun 2008 | - | -$10.36M(+39.6%) | -$26.25M(+40.2%) |
| Mar 2008 | - | -$7.42M(+73.0%) | -$18.73M(+20.7%) |
| Dec 2007 | -$15.51M(-17.5%) | -$4.29M(+2.7%) | -$15.51M(+5.7%) |
| Sep 2007 | - | -$4.18M(+47.1%) | -$14.67M(-11.8%) |
| Jun 2007 | - | -$2.84M(-32.4%) | -$16.63M(-17.3%) |
| Mar 2007 | - | -$4.20M(+22.0%) | -$20.12M(+7.0%) |
| Dec 2006 | -$18.79M(-0.4%) | -$3.45M(-43.9%) | -$18.79M(-4.2%) |
| Sep 2006 | - | -$6.14M(-2.8%) | -$19.63M(+8.2%) |
| Jun 2006 | - | -$6.32M(+119.6%) | -$18.15M(+8.5%) |
| Mar 2006 | - | -$2.88M(-32.7%) | -$16.72M(-11.3%) |
| Dec 2005 | -$18.86M | -$4.28M(-8.3%) | -$18.86M(+2.6%) |
| Sep 2005 | - | -$4.66M(-4.9%) | -$18.40M(+4.8%) |
| Jun 2005 | - | -$4.90M(-2.3%) | -$17.55M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | -$5.02M(+31.8%) | -$16.64M(+22.5%) |
| Dec 2004 | -$13.58M(+15.8%) | -$3.81M(-0.3%) | -$13.58M(+7.3%) |
| Sep 2004 | - | -$3.82M(-4.4%) | -$12.66M(+15.0%) |
| Jun 2004 | - | -$3.99M(+103.4%) | -$11.01M(+7.8%) |
| Mar 2004 | - | -$1.96M(-32.0%) | -$10.21M(-13.0%) |
| Dec 2003 | -$11.73M(-18.7%) | -$2.89M(+33.2%) | -$11.73M(-5.7%) |
| Sep 2003 | - | -$2.17M(-32.2%) | -$12.44M(+16.6%) |
| Jun 2003 | - | -$3.20M(-8.3%) | -$10.67M(-16.7%) |
| Mar 2003 | - | -$3.48M(-3.0%) | -$12.80M(-11.3%) |
| Dec 2002 | -$14.43M(-41.2%) | -$3.59M(+803.2%) | -$14.43M(-19.7%) |
| Sep 2002 | - | -$397.50K(-92.5%) | -$17.97M(-25.6%) |
| Jun 2002 | - | -$5.33M(+4.1%) | -$24.15M(-3.3%) |
| Mar 2002 | - | -$5.12M(-28.2%) | -$24.98M(+1.8%) |
| Dec 2001 | -$24.56M(+59.1%) | -$7.13M(+8.3%) | -$24.55M(+8.4%) |
| Sep 2001 | - | -$6.58M(+6.9%) | -$22.65M(+11.1%) |
| Jun 2001 | - | -$6.16M(+31.4%) | -$20.39M(+18.4%) |
| Mar 2001 | - | -$4.69M(-10.3%) | -$17.22M(+11.5%) |
| Dec 2000 | -$15.44M(+29.3%) | -$5.22M(+20.7%) | -$15.44M(+9.0%) |
| Sep 2000 | - | -$4.33M(+44.8%) | -$14.16M(+13.0%) |
| Jun 2000 | - | -$2.99M(+2.9%) | -$12.54M(+4.5%) |
| Mar 2000 | - | -$2.90M(-26.4%) | -$12.00M(-0.8%) |
| Dec 1999 | -$11.94M(+50.3%) | -$3.94M(+46.1%) | -$12.10M(+13.0%) |
| Sep 1999 | - | -$2.70M(+10.1%) | -$10.70M(+3.9%) |
| Jun 1999 | - | -$2.45M(-18.3%) | -$10.30M(+9.0%) |
| Mar 1999 | - | -$3.00M(+17.7%) | -$9.45M(+18.9%) |
| Dec 1998 | -$7.95M(+3.1%) | -$2.55M(+10.9%) | -$7.95M(+11.8%) |
| Sep 1998 | - | -$2.30M(+43.8%) | -$7.11M(+2.9%) |
| Jun 1998 | - | -$1.60M(+6.7%) | -$6.91M(-4.2%) |
| Mar 1998 | - | -$1.50M(-12.2%) | -$7.21M(-6.5%) |
| Dec 1997 | -$7.71M(-34.7%) | -$1.71M(-18.7%) | -$7.71M(-11.4%) |
| Sep 1997 | - | -$2.10M(+10.5%) | -$8.70M(-2.2%) |
| Jun 1997 | - | -$1.90M(-5.0%) | -$8.90M(-21.9%) |
| Mar 1997 | - | -$2.00M(-25.9%) | -$11.40M(-1.7%) |
| Dec 1996 | -$11.80M(0.0%) | -$2.70M(+17.4%) | -$11.60M(-4.1%) |
| Sep 1996 | - | -$2.30M(-47.7%) | -$12.10M(-7.6%) |
| Jun 1996 | - | -$4.40M(+100.0%) | -$13.10M(+15.9%) |
| Mar 1996 | - | -$2.20M(-31.3%) | -$11.30M(-4.2%) |
| Dec 1995 | -$11.80M(+24.2%) | -$3.20M(-3.0%) | -$11.80M(+9.3%) |
| Sep 1995 | - | -$3.30M(+26.9%) | -$10.80M(+8.0%) |
| Jun 1995 | - | -$2.60M(-3.7%) | -$10.00M(0.0%) |
| Mar 1995 | - | -$2.70M(+22.7%) | -$10.00M(+4.2%) |
| Dec 1994 | -$9.50M(+1.1%) | -$2.20M(-12.0%) | -$9.60M(-3.0%) |
| Sep 1994 | - | -$2.50M(-3.8%) | -$9.90M(-3.9%) |
| Jun 1994 | - | -$2.60M(+13.0%) | -$10.30M(+6.2%) |
| Mar 1994 | - | -$2.30M(-8.0%) | -$9.70M(+1.0%) |
| Dec 1993 | -$9.40M(+100.0%) | -$2.50M(-13.8%) | -$9.60M(+35.2%) |
| Sep 1993 | - | -$2.90M(+45.0%) | -$7.10M(+26.8%) |
| Jun 1993 | - | -$2.00M(-9.1%) | -$5.60M(+9.8%) |
| Mar 1993 | - | -$2.20M(+57.1%) | -$5.10M(-8.9%) |
| Dec 1992 | -$4.70M(-27.7%) | - | - |
| Oct 1992 | - | -$1.40M(-6.7%) | -$5.60M(-11.1%) |
| Jul 1992 | - | -$1.50M(-21.1%) | -$6.30M(-3.1%) |
| Apr 1992 | - | -$1.90M(+137.5%) | -$6.50M(+10.2%) |
| Apr 1992 | -$6.50M(+47.7%) | - | - |
| Jan 1992 | - | -$800.00K(-61.9%) | -$5.90M(-3.3%) |
| Oct 1991 | - | -$2.10M(+23.5%) | -$6.10M(+22.0%) |
| Jul 1991 | - | -$1.70M(+30.8%) | -$5.00M(+11.1%) |
| Apr 1991 | -$4.40M(+131.6%) | -$1.30M(+30.0%) | -$4.50M(+45.2%) |
| Jan 1991 | - | -$1.00M(0.0%) | -$3.10M(+34.8%) |
| Oct 1990 | - | -$1.00M(-16.7%) | -$2.30M(-309.1%) |
| Jul 1990 | - | -$1.20M(-1300.0%) | $1.10M(-75.0%) |
| Apr 1990 | -$1.90M(+18.8%) | $100.00K(-150.0%) | $4.40M(-257.1%) |
| Jan 1990 | - | -$200.00K(-108.3%) | -$2.80M(+300.0%) |
| Oct 1989 | - | $2.40M(+14.3%) | -$700.00K(-41.7%) |
| Jul 1989 | - | $2.10M(-129.6%) | -$1.20M(-25.0%) |
| Apr 1989 | -$1.60M(-20.0%) | -$7.10M(-473.7%) | -$1.60M(+433.3%) |
| Jan 1989 | - | $1.90M(0.0%) | -$300.00K(-57.1%) |
| Oct 1988 | - | $1.90M(+11.8%) | -$700.00K(-50.0%) |
| Jul 1988 | - | $1.70M(-129.3%) | -$1.40M(-33.3%) |
| Apr 1988 | -$2.00M(+25.0%) | -$5.80M(-486.7%) | -$2.10M(-2200.0%) |
| Jan 1988 | - | $1.50M(+25.0%) | $100.00K(-116.7%) |
| Oct 1987 | - | $1.20M(+20.0%) | -$600.00K(-50.0%) |
| Jul 1987 | - | $1.00M(-127.8%) | -$1.20M(-40.0%) |
| Apr 1987 | -$1.60M(-15.8%) | -$3.60M(-550.0%) | -$2.00M(+400.0%) |
| Jan 1987 | - | $800.00K(+33.3%) | -$400.00K(-63.6%) |
| Oct 1986 | - | $600.00K(+200.0%) | -$1.10M(-31.3%) |
| Jul 1986 | - | $200.00K(-110.0%) | -$1.60M(-5.9%) |
| Apr 1986 | -$1.90M | -$2.00M(-2100.0%) | -$1.70M(-666.7%) |
| Jan 1986 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Oct 1985 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jul 1985 | - | $100.00K | $100.00K |
FAQ
- What is Celldex Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Celldex Therapeutics?
- What is Celldex Therapeutics annual EBIT year-on-year change?
- What is Celldex Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly EBIT year-on-year change?
- What is Celldex Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Celldex Therapeutics?
- What is Celldex Therapeutics TTM EBIT year-on-year change?
What is Celldex Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CLDX is -$195.08M
What is the all time high annual EBIT for Celldex Therapeutics?
Celldex Therapeutics all-time high annual earnings before interest & taxes is -$1.20M
What is Celldex Therapeutics annual EBIT year-on-year change?
Over the past year, CLDX annual earnings before interest & taxes has changed by -$53.04M (-37.34%)
What is Celldex Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CLDX is -$62.74M
What is the all time high quarterly EBIT for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly earnings before interest & taxes is $26.43M
What is Celldex Therapeutics quarterly EBIT year-on-year change?
Over the past year, CLDX quarterly earnings before interest & taxes has changed by -$22.13M (-54.50%)
What is Celldex Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CLDX is -$217.21M
What is the all time high TTM EBIT for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM earnings before interest & taxes is $4.40M
What is Celldex Therapeutics TTM EBIT year-on-year change?
Over the past year, CLDX TTM earnings before interest & taxes has changed by -$67.03M (-44.63%)